ACUTE SEVERE ULCERATIVE COLITIS - CLINICAL AND TRANSLATIONAL STUDIES
Grant number: 1142945 | Funding period: 2018 - 2021
Active
Abstract
One in five patients with severe ulcerative colitis, a condition resulting in damage to the large bowel, may require surgery to remove the bowel. This project aims to find out how best to avoid surgery using a drug called infliximab which targets the immune system to reduce bowel damage. This study also aims to find changes in the immune system that cause ulcerative colitis and identify which patients are more likely to avoid surgery with infliximab thereby minimising side effects and costs.